Vical, Inc.
NASDAQ:VICL
$3.46
$0.10
(2.98%)
Quote as of 1:32 PM EST on 02/15/12
|
$3.46
$0.10
(2.98%)
|
|
| Today's Open | $3.39 |
|---|---|
| Previous Close | $3.36 |
| Daily Range | $3.32 - $3.48 |
| 52-Week Range | $1.79 - $5.30 |
| Market Cap | $248.71M |
| P/E Ratio | -33.60 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 513,468 |
| Average Daily Volume | 1,588,020 |
| Current FY EPS | -$0.33 |
VICL Information
| Description |
|---|
| The Company researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
Charting Vical's Latest Earnings Release
6 Key Drivers for Biotechnology's 2012 Outlook
Biopharmaceutical Co Vical Prices 13.3M Share Offering At 12% Discount
Ending HIV/AIDS: Hedge Funds Believe in These 5 Companies
Whoa! My Stock Just Crushed the Market!
Is Dendreon the Perfect Stock?
Vical's CEO Discusses Q2 2011 Results - Earnings Call Transcript
Exelixis, YM Biosciences Lead Losers at Cancer Meeting
